Introduction

Dementia is a broad term used to encompass a large group of illnesses defined by a progressive decline in a person’s functioning (e.g. memory, intellect, rationality, social skills and physicality). It is most frequently due to, but is not limited to, Alzheimer’s disease (AD). Mild cognitive impairment (MCI) is a preceding state that is also most commonly due to AD and is sometimes called prodromal AD.

Learning objectives

After successful completion of this CPD activity, pharmacists should be able to:

  • Define mild cognitive impairment, dementia and Alzheimer’s disease
  • Describe the signs, symptoms and diagnosis of mild cognitive impairment, dementia and Alzheimer’s disease
  • Summarise pharmacological and non-pharmacological interventions and any evidence for its use in mild cognitive impairment, dementia and Alzheimer’s disease.

Competencies (2016): 1.1, 1.2, 1.4, 1.5, 3.3, 3.5

 

This article was produced in partnership with Nutricia.

Alrea

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.